Logo

Rady Children's Institute for Genomic Medicine Scientific Advisory Board

Jan 04, 2018

The Rady Children's Institute for Genomic Medicine has named six individuals to its inaugural scientific advisory board. They are:

  • James Downing, president and CEO, St. Jude's Children's Research Hospital
  • Elizabeth Blackburn, president, Salk Institute for Biological Studies
  • George Church, professor, Wyss Institute at Harvard University
  • Cato Laurencin, university professor and distiguished professor, University of Connecticut
  • Thomas Insel, former director, National Institute of Mental Health at the National Institutes of Health; former director of mental health research, Verily Life Sciences; and currernt president, Mindstrong Health
  • Isaac Kohane, professor and chair of biomedical informatics, Harvard Medical School; and professor of pediatrics, Boston Children's Hospital
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.